Description
An orally-active quinoline-3-carboxamide that inhibits tumor angiogenesis and supplements radiation or chemotherapy in animal models of prostate cancer
Formal name: 1,2-dihydro-4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-3-quinolinecarboxamide
Synonyms: ABR-215050
Molecular weight: 406.4
CAS: 254964-60-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Angiogenesis||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors